AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou+5 more
wiley +1 more source
Molecular dynamics insights into non-covalent functionalization of boron nitride nanotubes for doxorubicin delivery. [PDF]
Ghavi Z, Torrik A, Rezaee M, Zarif M.
europepmc +1 more source
Decrypting cancer's spatial code: from single cells to tissue niches
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik+4 more
wiley +1 more source
Multi-laboratory comparisons of manual patch clamp hERG data generated using standardized protocols and following ICH S7B Q&A 2.1 best practices. [PDF]
Alvarez Baron C+25 more
europepmc +1 more source
THE PORTABILITY OF DRUGS IN FIELD SERVICE. [PDF]
Gillian Woodward, J.L Niven
openalex +1 more source
Microglia (BV2) and IL‐4‐treated BMDMs promote astrocytoma clustering and inhibit tumor growth, not shown in other macrophage cells. In vivo, microglial co‐implantation enhances CD8+ T cell infiltration, elevates Granzyme B, lowers circulating MDSCs, and extends survival only in immune‐competent mice, but not in immune‐deficient mice.
Tzu‐Chieh Sun+5 more
wiley +1 more source
Heterogeneous network drug-target interaction prediction model based on graph wavelet transform and multi-level contrastive learning. [PDF]
Dai W, Wang Y, Yan S, Yu Q, Cheng X.
europepmc +1 more source
TREATMENT OF MORPHIA HABITUÉS BY SUDDENLY DISCONTINUING THE DRUG. [PDF]
S. A. K. Strahan
openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts+8 more
wiley +1 more source
Polydopamine-coated double emulsion capsules for on-demand drug release with reduced passive leakage. [PDF]
Lee H, Nam G, Han D.
europepmc +1 more source